🕵️ Neogenomics Inc ($NEO)
SEC insider & ownership activity, last 12 months · CIK 1077183 · every row links its SEC filing
Over the last 12 months insiders sold $696K against $212K of open-market buying. Alicia C. Olivo sold $300K through a 10b5-1 trading plan in 2 lots (Oct–Nov). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
2 buyers, $212K (2 lots) · 3 sellers, $696K (5 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Alicia C. Olivo | 0 | – | 2 | $300K | Nov 25, 2025 |
| Stone Warren | 0 | – | 1 | $277K | Jan 20, 2026 |
| Lynn A. Tetrault | 0 | – | 2 | $119K | Jun 15, 2026 |
| Sherman Jeffrey Scott | 1 | $112K | 0 | – | Aug 6, 2025 |
| Anthony P. Zook | 1 | $100K | 0 | – | Aug 6, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Blackrock, Inc. | 14.6% | 13G | Oct 17, 2025 | filing ↗ | |
| Mathew P. Arens | 10.8% | 13G | May 7, 2026 | filing ↗ | |
| First Light Asset Management, LLC | 10.5% | 13G | May 7, 2026 | filing ↗ | |
| Greenhouse Funds Lllp | 7.1% | 13G | May 15, 2026 | filing ↗ | |
| Greenhouse GP LLC | 7.1% | 13G | May 15, 2026 | filing ↗ | |
| Joseph Milano | 7.1% | 13G | May 15, 2026 | filing ↗ | |
| Vanguard Portfolio Management | 5.9% | 13G | Apr 29, 2026 | filing ↗ | |
| Vanguard Capital Management | 5.1% | 13G | Apr 30, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Lynn Tetrault | $59K | Jun 15, 2026 | filing ↗ |
| Lynn Tetrault | $58K | Jun 9, 2026 | filing ↗ |
| Warren Stone | $283K | Jan 20, 2026 | filing ↗ |
| Alicia Olivo | $139K | Nov 25, 2025 | filing ↗ |
| Alicia Olivo | $49K | Oct 16, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Jul 28, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 28, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jul 20, 2026 | filing ↗ |
| Other events (8.01) | Jul 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 20, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jul 20, 2026 | filing ↗ |
| Other events (8.01) | Jul 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 20, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 23, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 23, 2026 | filing ↗ |
| Other events (8.01) | Jun 17, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 17, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 16, 2026 | filing ↗ |
| New financial obligation (2.03) | Jun 16, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jun 16, 2026 | filing ↗ |
| Other events (8.01) | Jun 16, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 16, 2026 | filing ↗ |
| Other events (8.01) | Jun 15, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 15, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 21, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 21, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 21, 2026 | filing ↗ |
| Earnings (2.02) | Apr 28, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 28, 2026 | filing ↗ |
| Earnings (2.02) | Feb 17, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 17, 2026 | filing ↗ |
| Earnings (2.02) | Jan 9, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jan 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 9, 2026 | filing ↗ |